Literature DB >> 30305310

Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.

Suchun Li1, Miaojuan Qiu1, Yonglun Kong1, Xiaoduo Zhao1, Hyo-Jung Choi2, Maria Reich3, Brady H Bunkelman4, Qiaojuan Liu1, Shan Hu1, Mengke Han1, Haixia Xie1, Avi Z Rosenberg4,5, Verena Keitel3, Tae-Hwan Kwon2, Moshe Levi6, Chunling Li7, Weidong Wang7.   

Abstract

BACKGROUND: The bile acid-activated receptors, including the membrane G protein-coupled receptor TGR5 and nuclear farnesoid X receptor (FXR), have roles in kidney diseases. In this study, we investigated the role of TGR5 in renal water handling and the underlying molecular mechanisms.
METHODS: We used tubule suspensions of inner medullary collecting duct (IMCD) cells from rat kidneys to investigate the effect of TGR5 signaling on aquaporin-2 (AQP2) expression, and examined the in vivo effects of TGR5 in mice with lithium-induced nephrogenic diabetes insipidus (NDI) and Tgr5 knockout (Tgr5 -/-) mice.
RESULTS: Activation of TGR5 by lithocholic acid (LCA), an endogenous TGR5 ligand, or INT-777, a synthetic TGR5-specific agonist, induced AQP2 expression and intracellular trafficking in rat IMCD cells via a cAMP-protein kinase A signaling pathway. In mice with NDI, dietary supplementation with LCA markedly decreased urine output and increased urine osmolality, which was associated with significantly upregulated AQP2 expression in the kidney inner medulla. Supplementation with endogenous FXR agonist had no effect. In primary IMCD suspensions from lithium-treated rats, treatment with INT-767 (FXR and TGR5 dual agonist) or INT-777, but not INT-747 (FXR agonist), increased AQP2 expression. Tgr5 -/- mice exhibited an attenuated ability to concentrate urine in response to dehydration, which was associated with decreased AQP2 expression in the kidney inner medulla. In lithium-treated Tgr5 -/- mice, LCA treatment failed to prevent reduction of AQP2 expression.
CONCLUSIONS: TGR5 stimulation increases renal AQP2 expression and improves impaired urinary concentration in lithium-induced NDI. TGR5 is thus involved in regulating water metabolism in the kidney.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  AQP2; TGR5; cAMP; lithium

Mesh:

Substances:

Year:  2018        PMID: 30305310      PMCID: PMC6218869          DOI: 10.1681/ASN.2018030271

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  32 in total

Review 1.  Molecular physiology of water balance.

Authors:  Mark A Knepper; Tae-Hwan Kwon; Soren Nielsen
Journal:  N Engl J Med       Date:  2015-04-02       Impact factor: 91.245

2.  Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation.

Authors:  Galya Vassileva; Andrei Golovko; Lisa Markowitz; Susan J Abbondanzo; Ming Zeng; Shijun Yang; Lizbeth Hoos; Glen Tetzloff; Diane Levitan; Nicholas J Murgolo; Kevin Keane; Harry R Davis; Joseph Hedrick; Eric L Gustafson
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

3.  The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes.

Authors:  Verena Keitel; Christoph Ullmer; Dieter Häussinger
Journal:  Biol Chem       Date:  2010-07       Impact factor: 3.915

4.  G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.

Authors:  Xiaoxin X Wang; Michal Herman Edelstein; Uzi Gafter; Liru Qiu; Yuhuan Luo; Evgenia Dobrinskikh; Scott Lucia; Luciano Adorini; Vivette D D'Agati; Jonathan Levi; Avi Rosenberg; Jeffrey B Kopp; David R Gius; Moin A Saleem; Moshe Levi
Journal:  J Am Soc Nephrol       Date:  2015-09-30       Impact factor: 10.121

5.  Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.

Authors:  Reena Rao; Ming-Zhi Zhang; Min Zhao; Hui Cai; Raymond C Harris; Matthew D Breyer; Chuan-Ming Hao
Journal:  Am J Physiol Renal Physiol       Date:  2004-12-07

6.  Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice.

Authors:  Xiaoyan Zhang; Shizheng Huang; Min Gao; Jia Liu; Xiao Jia; Qifei Han; Senfeng Zheng; Yifei Miao; Shuo Li; Haoyu Weng; Xuan Xia; Shengnan Du; Wanfu Wu; Jan-Åke Gustafsson; Youfei Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-24       Impact factor: 11.205

7.  GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.

Authors:  Reena Rao; Satish Patel; Chuanming Hao; James Woodgett; Raymond Harris
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

Review 8.  Bile acids: emerging role in management of liver diseases.

Authors:  Amon Asgharpour; Divya Kumar; Arun Sanyal
Journal:  Hepatol Int       Date:  2015-08-29       Impact factor: 6.047

9.  The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity.

Authors:  Evie P M Broeders; Emmani B M Nascimento; Bas Havekes; Boudewijn Brans; Kay H M Roumans; Anne Tailleux; Gert Schaart; Mostafa Kouach; Julie Charton; Benoit Deprez; Nicole D Bouvy; Felix Mottaghy; Bart Staels; Wouter D van Marken Lichtenbelt; Patrick Schrauwen
Journal:  Cell Metab       Date:  2015-07-30       Impact factor: 27.287

10.  Bile acids have the gall to function as hormones.

Authors:  Thomas Quad de Aguiar Vallim; Peter A Edwards
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

View more
  12 in total

Review 1.  Bile acids and salt-sensitive hypertension: a role of the gut-liver axis.

Authors:  Jeanne A Ishimwe; Thanvi Dola; Lale A Ertuglu; Annet Kirabo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-04       Impact factor: 4.733

Review 2.  Aquaporins Display a Diversity in their Substrates.

Authors:  Ruchi Sachdeva; Pragya Priyadarshini; Sakshi Gupta
Journal:  J Membr Biol       Date:  2022-08-20       Impact factor: 2.426

3.  Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene.

Authors:  Bin Wang; Yao Wang; Yi Wen; Yi-Lin Zhang; Wei-Jie Ni; Tao-Tao Tang; Jing-Yuan Cao; Qing Yin; Wei Jiang; Di Yin; Zuo-Lin Li; Lin-Li Lv; Bi-Cheng Liu
Journal:  Mol Ther       Date:  2022-05-16       Impact factor: 12.910

4.  Activation of TGR5 with INT-777 attenuates oxidative stress and neuronal apoptosis via cAMP/PKCε/ALDH2 pathway after subarachnoid hemorrhage in rats.

Authors:  Gang Zuo; Tongyu Zhang; Lei Huang; Camila Araujo; Jun Peng; Zachary Travis; Takeshi Okada; Umut Ocak; Guangyu Zhang; Jiping Tang; Xiaojun Lu; John H Zhang
Journal:  Free Radic Biol Med       Date:  2019-09-04       Impact factor: 7.376

Review 5.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

Review 6.  Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases.

Authors:  Emma T B Olesen; Robert A Fenton
Journal:  Nat Rev Nephrol       Date:  2021-07-01       Impact factor: 28.314

7.  New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus.

Authors:  Hyun Jun Jung; Tae-Hwan Kwon
Journal:  Kidney Res Clin Pract       Date:  2019-06-30

Review 8.  Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gabriella Garruti; Mirco Vacca; Maria De Angelis; David Q-H Wang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

Review 9.  Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases.

Authors:  Fangling Zhang; Xiaolin Xiao; Yong Li; Hefei Wu; Xinyu Deng; Yinxiao Jiang; Wenwen Zhang; Jian Wang; Xiao Ma; Yanling Zhao
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 10.  AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.

Authors:  Chao Gao; Paul J Higgins; Wenzheng Zhang
Journal:  Cells       Date:  2020-09-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.